10.6084/m9.figshare.9969263.v1
Fujun Li
Fujun
Li
Lixia Miao
Lixia
Miao
Teng Xue
Teng
Xue
Hao Qin
Hao
Qin
Santanu Mondal
Santanu
Mondal
Paul Thompson
Paul
Thompson
Scott Coonrod
Scott
Coonrod
Xiaoqiu Liu
Xiaoqiu
Liu
Xuesen Zhang
Xuesen
Zhang
MOESM7 of Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells
Springer Nature
2019
Breast cancer
Tamoxifen-resistance
PAD2
Docetaxel
2019-10-11 05:37:29
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/MOESM7_of_Inhibiting_PAD2_enhances_the_anti-tumor_effect_of_docetaxel_in_tamoxifen-resistant_breast_cancer_cells/9969263
Additional file 7. Figure S7. Western blot analysis showing that pretreatment of PAD2 knockdown (a) or miR-125b-5p overexpression (b) MCF7/TamR cells with 10 ÎźM MHY1485 abolished the inhibitory effect of docetaxel on Rps6 activation. GAPDH served as loading control; shPAD2: PAD2 knockdown MCF7/TamR cells; miR-125b-5p: miR-125b-5p overexpression MCF7/TamR cells; Doc: docetaxel; PBS was used as a control.